title: Continuing to strengthen FDA's science approach to emerging technologies.
abstract: Emerging technologies result when advances and innovation in technology lead to discoveries. Often emerging technologies stimulate novel research in medical product development that contribute to new approaches to manufacturing and can improve the quality of products. By supporting investments in agency coordination, staff training and professional development, regulatory science research, stakeholder engagement, and enhancing opportunities for expert input, the U.S. Food and Drug Administration plays a critical role in translating innovations into novel safe and effective medical products that improve the public health.
authors.affiliation: Emerging Technology Programs, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Rachael
authors.initials: R
authors.lastname: Anatol
authors.forename: Steven
authors.initials: S
authors.lastname: Bauer
authors.forename: Suzanne
authors.initials: S
authors.lastname: Epstein
authors.forename: Ross
authors.initials: R
authors.lastname: Filice
authors.forename: Kristina
authors.initials: K
authors.lastname: Lauritsen
authors.forename: Mark H
authors.initials: MH
authors.lastname: Lee
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Mansfield
authors.forename: Michelle
authors.initials: M
authors.lastname: McMurry-Heath
authors.forename: Joseph
authors.initials: J
authors.lastname: Milone
authors.forename: Carlos
authors.initials: C
authors.lastname: Peña
authors.forename: Steven
authors.initials: S
authors.lastname: Pollack
authors.forename: Issam
authors.initials: I
authors.lastname: Zineh
mesh_terms: D006801:Humans; D007449:Investments / Q000191:economics*; D036103:Nanotechnology / Q000191:economics*; D011634:Public Health; D012106:Research / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics*